Skip to contentMAIER PAUL V — LIGAND PHARMACEUTICALS INC insider: 370 transactions · InsiderLensMAIER PAUL V
- Sr. V-P, CFO at LIGAND PHARMACEUTICALS INC · on record since Mar 14, 2006
- Director at BTHC III INC. · on record since Jul 24, 2007
- Director at PURE BIOSCIENCE · on record since Jan 24, 2008
- Director at Hana Biosciences Inc · on record since Mar 21, 2008
- Chief Financial Officer at SEQUENOM INC · on record since Apr 21, 2010
- Director at NEXMED INC · on record since Jun 5, 2012
- Director at TELIK INC · on record since Jul 17, 2014
- Director at AIxCrypto Holdings, Inc. · on record since Jun 24, 2015
- Director at Eton Pharmaceuticals, Inc. · on record since Nov 15, 2018
- Director at Ambrx Biopharma Inc. · on record since Jan 31, 2023
Insider trading activity of MAIER PAUL V
- Transactions on record
- 370
- since Nov 21, 2003
- Open-market buys
- 23
- $78.8K
- Open-market sells
- 119
- $2.2M
- Companies traded
- 10
- last filing Jun 23, 2026
Figures computed from official regulatory filings — methodology.
Companies where MAIER PAUL V has traded
- BTHC III INC.73 tx · $388.7K · Jun 23, 2026
- Eton Pharmaceuticals, Inc.10 tx · $30K · Jan 14, 2026
- Ambrx Biopharma Inc.8 tx · Mar 7, 2024
- AIxCrypto Holdings, Inc.5 tx · Jan 17, 2020
- TELIK INC24 tx · $348.8K · Apr 4, 2018
- NEXMED INC11 tx · $10.9K · Jan 8, 2018
- SEQUENOM INC55 tx · $36K · Feb 12, 2014
- Hana Biosciences Inc16 tx · $5.3K · Jul 18, 2013
- PURE BIOSCIENCE6 tx · $174.5K · Aug 2, 2012
- LIGAND PHARMACEUTICALS INC
Track record of MAIER PAUL V
Statistical track record
Free- Open-market buys
- 23
- Last buy
- Nov 15, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of MAIER PAUL V
Co-insiders of MAIER PAUL V
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
162 tx · $3.6M · Nov 22, 2006
Abdul-Ahad WajdiAIxCrypto Holdings, Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 23, 2026 | AwardD | 30,000 | 0.00 USD | — | SEC |
| Jun 23, 2026 | AwardD | 182,584 | 0.00 USD | — | SEC |
| Jan 14, 2026 | AwardD | 12,196 | 0.00 USD | $0 | SEC |
| Jan 14, 2026 | AwardD | 7,757 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 532,786 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | AwardD | 25,000 | 0.00 USD | $0 | SEC |
| Jun 13, 2024 | AwardD | 361,111 | 0.00 USD | $0 | SEC |
| Jun 13, 2024 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Mar 7, 2024 | OtherD | -15,000 | — | — | SEC |
| Mar 7, 2024 | OtherD | -30,000 | — | — | SEC |
| Mar 7, 2024 | OtherD | -12,142 | — | — | SEC |
| Feb 15, 2024 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 445,205 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 9, 2023 | Award | 85,000 | 0.00 USD | $0 | SEC |
| Mar 3, 2023 | AwardD | 25,000 | 0.00 USD | $0 | SEC |
| Jan 31, 2023 | AwardD | 105,000 | — | — | SEC |
| Jan 31, 2023 | OtherD | -210,000 | — | — | SEC |
| Jan 31, 2023 | AwardD | 210,000 | — | — | SEC |
| Jan 31, 2023 | OtherD | -105,000 | — | — | SEC |
| Jun 10, 2022 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 10, 2022 | AwardD | 139,264 | 0.00 USD | $0 | SEC |
| Feb 28, 2022 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Jun 11, 2021 | AwardD | 30,000 | 0.00 USD | $0 | SEC |